Crystal structures of human glycerol 3-phosphate dehydrogenase 1 (GPD1)

被引:104
作者
Ou, XJ
Ji, CN
Han, XQ
Zhao, XD
Li, XM
Mao, YM
Wong, LL
Bartlam, M
Rao, ZH [1 ]
机构
[1] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China
[2] Tsing Hua Univ, Tsinghua IBP Joint Res Grp Struct Biol, Beijing 100084, Peoples R China
[3] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China
[4] Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England
基金
中国国家自然科学基金;
关键词
L-alpha-glycerol-3-phosphate dehydrogenase 1; NAD-dependent dehydrogenase; crystal structure; catalytic mechanism; DHAP accumulation;
D O I
10.1016/j.jmb.2005.12.074
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Homo sapiens L-alpha-glycerol-3-phosphate dehydrogenase 1 (GPD1) catalyzes the reversible biological conversion of dihydroxyacetone (DHAP) to glycerol-3-phosphate. The GPD1 protein was expressed in Escherichia coli, and purified as a fusion protein with glutathione S-transferase. Here we report the apoenzyme structure of GPD1 determined by multiwavelength anomalous diffraction phasing, and other complex structures with small I molecules (NAD+ and DHAP) by the molecular replacement method. This enzyme structure is organized into two distinct domains, the N-terminal eight-stranded beta-sheet sandwich domain and the C-terminal helical substrate-binding domain. An electrophilic catalytic mechanism by the epsilon-NH3+ group of Lys204 is proposed on the basis of the structural analyses. In addition, the inhibitory effects of zinc and sulfate on GPDHs are assayed and discussed. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:858 / 869
页数:12
相关论文
共 24 条
[1]   Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase [J].
Aronov, AM ;
Suresh, S ;
Buckner, FS ;
Van Voorhis, WC ;
Verlinde, CLMJ ;
Opperdoes, FR ;
Hol, WGJ ;
Gelb, MH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4273-4278
[2]  
Banaszak LJ., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3
[3]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[4]  
Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.0.CO
[5]  
2-N
[6]  
COLONNACESARI F, 1986, J BIOL CHEM, V261, P5273
[7]   Affinity chromatography using trypanocidal arsenical drugs identifies a specific interaction between glycerol-3-phosphate dehydrogenase from Trypanosoma brucei and Cymelarsan [J].
Denise, H ;
Giroud, C ;
Barrett, MP ;
Baltz, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 259 (1-2) :339-346
[8]   Prospects for antiparasitic drugs -: The case of Trypanosoma brucei, the causative agent of African sleeping sickness [J].
Eisenthal, R ;
Cornish-Bowden, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5500-5505
[9]   Phase determination from multiwavelength anomalous diffraction measurements [J].
Hendrickson, WA ;
Ogata, CM .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :494-523
[10]   RARE ELECTROPHORETIC VARIANTS OF GLYCEROL-3-PHOSPHATE DEHYDROGENASE - EVIDENCE FOR 2 STRUCTURAL GENE LOCI (GPD1 AND GPD2) [J].
HOPKINSON, DA ;
PETERS, J ;
HARRIS, H .
ANNALS OF HUMAN GENETICS, 1974, 37 (MAY) :477-484